U.S. Markets open in 1 hr 38 mins

Zynex, Inc. (ZYXI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
13.96+0.09 (+0.65%)
At close: 4:00PM EST

14.12 +0.16 (1.15%)
Before hours: 7:46AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.87
Open13.87
Bid13.20 x 1800
Ask0.00 x 900
Day's Range13.71 - 14.16
52 Week Range7.51 - 29.73
Volume444,795
Avg. Volume746,442
Market Cap484.984M
Beta (5Y Monthly)0.91
PE Ratio (TTM)46.53
EPS (TTM)0.30
Earnings DateOct 27, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 31, 2018
1y Target Est25.75
  • Zynex Ranked 13th in Revenue Growth Among Medical Device Companies
    PR Newswire

    Zynex Ranked 13th in Revenue Growth Among Medical Device Companies

    Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced it has been ranked 13th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte's 2020 Technology Fast 500. Zynex was ranked 388th for revenue growth between 2016 and 2019 across all companies in North America. Zynex's revenues grew 242% over that period, with 2019 revenue reaching $45.5 million. The company estimates 2020 revenue between $80.0 and $81.0 million. The 2020 Deloitte Technology Fast 500 list can be found at www.fast500.com.

  • Zynex to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
    PR Newswire

    Zynex to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

    Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced the Company will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3. The Company will be participating in 1X1 meetings from December 1st-3rd, meetings may be requested exclusively via Piper Sandler.

  • Zynex, Inc.'s (NASDAQ:ZYXI) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
    Simply Wall St.

    Zynex, Inc.'s (NASDAQ:ZYXI) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

    Zynex (NASDAQ:ZYXI) has had a rough three months with its share price down 31%. However, a closer look at its sound...